LOGO H8 (Micardis HCT 12.5 mg / 80 mg)
Generic Name: hydrochlorothiazide/telmisartan
Pill imprint LOGO H8 has been identified as Micardis HCT 12.5 mg / 80 mg.
Micardis HCT is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Micardis HCT 12.5 mg / 80 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- LOGO H8
- 12.5 mg / 80 mg
- Red & White
- 16.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Angiotensin II inhibitors with thiazides
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Boehringer Ingelheim Pharmaceuticals, Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|00054-0546||Roxane Laboratories, Inc.|
|54868-4540||Physicians Total Care Inc (repackager)|
|54569-5665||A-S Medication Solutions, LLC (repackager)|
|35356-0299||Lake Erie Medical and Surgical Supply (repackager)|
More about Micardis HCT (hydrochlorothiazide / telmisartan)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 12 Reviews – Add your own review/rating
- Generic Availability
- Drug class: angiotensin II inhibitors with thiazides
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.